We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




E-cigarettes Contain Multiple Carcinogens

By HospiMedica International staff writers
Posted on 10 Dec 2014
A new study reveals that e-cigarettes can contain up to 10 times the level of cancer-causing agents than regular tobacco, including formaldehyde and acetaldehyde.

Researchers at the at Japanese National Institute of Public Health (Saitama, Japan) analyzed 13 cartridges of e-cigarette fluid using a smoking machine that "inhaled" 10 sets of 15 puffs. More...
A range of hazardous compounds were found in the e-cigarettes, particularly carbonyl compounds such as formaldehyde, acetaldehyde, acetone, acrolein, propanal, crotonaldehyde, butanal, glyoxal, and methylglyoxal. The carbonyl compounds are generated by the vaporization of the e-liquid when it contacts with the heated nickel-chromium (nichrome) atomizer.

The researchers found that the results of the smoking machine tests varied, depending on the type of e-liquid in the cartridge, the compositions and concentrations of the compounds, and the battery voltage of the atomizer. One brand, the name of which was not revealed, showed a more than 10-fold level of formaldehyde on 9 out of every 10 sets. Another brand showed similar levels on several sets, but was not consistently that high. The study was published on October 28, 2014, in the International Journal of Environmental Research and Public Health.

“Very high amounts of formaldehyde were measured. Glyoxal and methylglyoxal, which show mutagenicity, are specific to e-cigarette aerosols and have been minimally detected in the mainstream smoke from traditional cigarettes,” concluded senior author Prof. Naoki Kunugita, MD, PhD, and colleagues. “The amount of carbonyl compounds in these brands of e-cigarettes varied significantly not only among different brands but also among different samples of the same products. However, in most cases, the levels are lower than those in tobacco cigarette smoke.”

Nicotine e-cigarettes, or electronic nicotine delivery systems (ENDS), were first developed by Herbert A. Gilbert, who patented a device described as “a smokeless non-tobacco cigarette” that involved “replacing burning tobacco and paper with heated, moist, flavored air” in 1963. However, the invention of the modern e-cigarette in 2003 is attributed to Hon Lik, a Chinese pharmacist, who introduced them to the Chinese market as a smoking cessation device in 2004.

Related Links:

Japanese National Institute of Public Health



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.